Skip to main content

MoneyWorks4Me

Granules India informs about press release

31 Jan 2022 Evaluate

Granules India has informed that it enclosed the press release on January 31st ,2022 titled ‘Granules Pharmaceuticals, Inc. concludes US FDA Audit with Three Minor Observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..